Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Buy
59
LIVN Quote, Financials, Valuation and Earnings
Last price:
$64.43
Seasonality move
:
1.32%
Day range:
$64.13 - $65.07
52-week range:
$32.48 - $65.57
Dividend yield:
0%
P/E ratio:
38.16x
P/S ratio:
2.61x
P/B ratio:
3.04x
Volume:
408.3K
Avg. volume:
560K
1-year change:
34.08%
Market cap:
$3.5B
Revenue:
$1.3B
EPS (TTM):
-$4.01
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
LIVN
LivaNova Plc
|
$353.3M | $0.81 | 9.77% | -20.8% | $72.82 |
|
ABT
Abbott Laboratories
|
$11.8B | $1.50 | 8.1% | 61.63% | $144.75 |
|
ATEC
Alphatec Holdings, Inc.
|
$209.2M | $0.04 | 18.33% | -91.85% | $24.92 |
|
ATRC
AtriCure, Inc.
|
$139.3M | -$0.05 | 12.08% | -83.91% | $52.33 |
|
IRTC
iRhythm Technologies, Inc.
|
$199.8M | $0.06 | 21.66% | -80.89% | $220.27 |
|
NVCR
NovoCure Ltd.
|
$168.9M | -$0.39 | 4.75% | -35.35% | $24.79 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
LIVN
LivaNova Plc
|
$64.41 | $72.82 | $3.5B | 38.16x | $0.00 | 0% | 2.61x |
|
ABT
Abbott Laboratories
|
$125.92 | $144.75 | $219B | 15.79x | $0.59 | 1.87% | 5.02x |
|
ATEC
Alphatec Holdings, Inc.
|
$22.65 | $24.92 | $3.4B | -- | $0.00 | 0% | 4.61x |
|
ATRC
AtriCure, Inc.
|
$41.46 | $52.33 | $2.1B | -- | $0.00 | 0% | 3.80x |
|
IRTC
iRhythm Technologies, Inc.
|
$179.43 | $220.27 | $5.8B | -- | $0.00 | 0% | 8.11x |
|
NVCR
NovoCure Ltd.
|
$14.35 | $24.79 | $1.6B | -- | $0.00 | 0% | 2.47x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
LIVN
LivaNova Plc
|
29.6% | 1.670 | 17.01% | 1.05x |
|
ABT
Abbott Laboratories
|
20.25% | 0.321 | 5.99% | 1.12x |
|
ATEC
Alphatec Holdings, Inc.
|
94.39% | 1.682 | 27.26% | 1.21x |
|
ATRC
AtriCure, Inc.
|
14.82% | 1.966 | 4.73% | 2.72x |
|
IRTC
iRhythm Technologies, Inc.
|
85.74% | 2.412 | 13.23% | 4.47x |
|
NVCR
NovoCure Ltd.
|
70.04% | 0.578 | 55.15% | 1.44x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
LIVN
LivaNova Plc
|
$244.9M | $56.6M | -12.15% | -18.29% | 15.83% | $62.2M |
|
ABT
Abbott Laboratories
|
$5.9B | $2.2B | 22.49% | 29.06% | 19.03% | $2.3B |
|
ATEC
Alphatec Holdings, Inc.
|
$118.1M | -$9.4M | -25.96% | -1495.13% | -4.79% | $3.1M |
|
ATRC
AtriCure, Inc.
|
$100.6M | $208K | -5.3% | -6.2% | 0.16% | $24.1M |
|
IRTC
iRhythm Technologies, Inc.
|
$137.1M | -$4M | -6.2% | -54.18% | -2.08% | $20.1M |
|
NVCR
NovoCure Ltd.
|
$122.5M | -$36M | -16.67% | -50.08% | -21.54% | $14.9M |
LivaNova Plc vs. Competitors
-
Which has Higher Returns LIVN or ABT?
Abbott Laboratories has a net margin of 7.49% compared to LivaNova Plc's net margin of 14.07%. LivaNova Plc's return on equity of -18.29% beat Abbott Laboratories's return on equity of 29.06%.
Company Gross Margin Earnings Per Share Invested Capital LIVNLivaNova Plc68.44% $0.49 $1.6B ABTAbbott Laboratories52.05% $0.91 $64.2B -
What do Analysts Say About LIVN or ABT?
LivaNova Plc has a consensus price target of $72.82, signalling upside risk potential of 13.05%. On the other hand Abbott Laboratories has an analysts' consensus of $144.75 which suggests that it could grow by 14.95%. Given that Abbott Laboratories has higher upside potential than LivaNova Plc, analysts believe Abbott Laboratories is more attractive than LivaNova Plc.
Company Buy Ratings Hold Ratings Sell Ratings LIVNLivaNova Plc6 2 0 ABTAbbott Laboratories15 7 0 -
Is LIVN or ABT More Risky?
LivaNova Plc has a beta of 0.973, which suggesting that the stock is 2.741% less volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.721, suggesting its less volatile than the S&P 500 by 27.854%.
-
Which is a Better Dividend Stock LIVN or ABT?
LivaNova Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 1.87% to investors and pays a quarterly dividend of $0.59 per share. LivaNova Plc pays -- of its earnings as a dividend. Abbott Laboratories pays out 29.33% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios LIVN or ABT?
LivaNova Plc quarterly revenues are $357.8M, which are smaller than Abbott Laboratories quarterly revenues of $11.4B. LivaNova Plc's net income of $26.8M is lower than Abbott Laboratories's net income of $1.6B. Notably, LivaNova Plc's price-to-earnings ratio is 38.16x while Abbott Laboratories's PE ratio is 15.79x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LivaNova Plc is 2.61x versus 5.02x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LIVNLivaNova Plc2.61x 38.16x $357.8M $26.8M ABTAbbott Laboratories5.02x 15.79x $11.4B $1.6B
-
Which has Higher Returns LIVN or ATEC?
Alphatec Holdings, Inc. has a net margin of 7.49% compared to LivaNova Plc's net margin of -14.54%. LivaNova Plc's return on equity of -18.29% beat Alphatec Holdings, Inc.'s return on equity of -1495.13%.
Company Gross Margin Earnings Per Share Invested Capital LIVNLivaNova Plc68.44% $0.49 $1.6B ATECAlphatec Holdings, Inc.60.12% -$0.19 $626.3M -
What do Analysts Say About LIVN or ATEC?
LivaNova Plc has a consensus price target of $72.82, signalling upside risk potential of 13.05%. On the other hand Alphatec Holdings, Inc. has an analysts' consensus of $24.92 which suggests that it could grow by 10.04%. Given that LivaNova Plc has higher upside potential than Alphatec Holdings, Inc., analysts believe LivaNova Plc is more attractive than Alphatec Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings LIVNLivaNova Plc6 2 0 ATECAlphatec Holdings, Inc.8 1 0 -
Is LIVN or ATEC More Risky?
LivaNova Plc has a beta of 0.973, which suggesting that the stock is 2.741% less volatile than S&P 500. In comparison Alphatec Holdings, Inc. has a beta of 1.013, suggesting its more volatile than the S&P 500 by 1.311%.
-
Which is a Better Dividend Stock LIVN or ATEC?
LivaNova Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alphatec Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LivaNova Plc pays -- of its earnings as a dividend. Alphatec Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LIVN or ATEC?
LivaNova Plc quarterly revenues are $357.8M, which are larger than Alphatec Holdings, Inc. quarterly revenues of $196.5M. LivaNova Plc's net income of $26.8M is higher than Alphatec Holdings, Inc.'s net income of -$28.6M. Notably, LivaNova Plc's price-to-earnings ratio is 38.16x while Alphatec Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LivaNova Plc is 2.61x versus 4.61x for Alphatec Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LIVNLivaNova Plc2.61x 38.16x $357.8M $26.8M ATECAlphatec Holdings, Inc.4.61x -- $196.5M -$28.6M
-
Which has Higher Returns LIVN or ATRC?
AtriCure, Inc. has a net margin of 7.49% compared to LivaNova Plc's net margin of -0.2%. LivaNova Plc's return on equity of -18.29% beat AtriCure, Inc.'s return on equity of -6.2%.
Company Gross Margin Earnings Per Share Invested Capital LIVNLivaNova Plc68.44% $0.49 $1.6B ATRCAtriCure, Inc.74.9% -$0.01 $559.4M -
What do Analysts Say About LIVN or ATRC?
LivaNova Plc has a consensus price target of $72.82, signalling upside risk potential of 13.05%. On the other hand AtriCure, Inc. has an analysts' consensus of $52.33 which suggests that it could grow by 26.23%. Given that AtriCure, Inc. has higher upside potential than LivaNova Plc, analysts believe AtriCure, Inc. is more attractive than LivaNova Plc.
Company Buy Ratings Hold Ratings Sell Ratings LIVNLivaNova Plc6 2 0 ATRCAtriCure, Inc.5 0 0 -
Is LIVN or ATRC More Risky?
LivaNova Plc has a beta of 0.973, which suggesting that the stock is 2.741% less volatile than S&P 500. In comparison AtriCure, Inc. has a beta of 1.401, suggesting its more volatile than the S&P 500 by 40.078%.
-
Which is a Better Dividend Stock LIVN or ATRC?
LivaNova Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AtriCure, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LivaNova Plc pays -- of its earnings as a dividend. AtriCure, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LIVN or ATRC?
LivaNova Plc quarterly revenues are $357.8M, which are larger than AtriCure, Inc. quarterly revenues of $134.3M. LivaNova Plc's net income of $26.8M is higher than AtriCure, Inc.'s net income of -$267K. Notably, LivaNova Plc's price-to-earnings ratio is 38.16x while AtriCure, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LivaNova Plc is 2.61x versus 3.80x for AtriCure, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LIVNLivaNova Plc2.61x 38.16x $357.8M $26.8M ATRCAtriCure, Inc.3.80x -- $134.3M -$267K
-
Which has Higher Returns LIVN or IRTC?
iRhythm Technologies, Inc. has a net margin of 7.49% compared to LivaNova Plc's net margin of -2.7%. LivaNova Plc's return on equity of -18.29% beat iRhythm Technologies, Inc.'s return on equity of -54.18%.
Company Gross Margin Earnings Per Share Invested Capital LIVNLivaNova Plc68.44% $0.49 $1.6B IRTCiRhythm Technologies, Inc.71.09% -$0.16 $854.9M -
What do Analysts Say About LIVN or IRTC?
LivaNova Plc has a consensus price target of $72.82, signalling upside risk potential of 13.05%. On the other hand iRhythm Technologies, Inc. has an analysts' consensus of $220.27 which suggests that it could grow by 22.76%. Given that iRhythm Technologies, Inc. has higher upside potential than LivaNova Plc, analysts believe iRhythm Technologies, Inc. is more attractive than LivaNova Plc.
Company Buy Ratings Hold Ratings Sell Ratings LIVNLivaNova Plc6 2 0 IRTCiRhythm Technologies, Inc.12 1 0 -
Is LIVN or IRTC More Risky?
LivaNova Plc has a beta of 0.973, which suggesting that the stock is 2.741% less volatile than S&P 500. In comparison iRhythm Technologies, Inc. has a beta of 1.121, suggesting its more volatile than the S&P 500 by 12.075%.
-
Which is a Better Dividend Stock LIVN or IRTC?
LivaNova Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. iRhythm Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LivaNova Plc pays -- of its earnings as a dividend. iRhythm Technologies, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LIVN or IRTC?
LivaNova Plc quarterly revenues are $357.8M, which are larger than iRhythm Technologies, Inc. quarterly revenues of $192.9M. LivaNova Plc's net income of $26.8M is higher than iRhythm Technologies, Inc.'s net income of -$5.2M. Notably, LivaNova Plc's price-to-earnings ratio is 38.16x while iRhythm Technologies, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LivaNova Plc is 2.61x versus 8.11x for iRhythm Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LIVNLivaNova Plc2.61x 38.16x $357.8M $26.8M IRTCiRhythm Technologies, Inc.8.11x -- $192.9M -$5.2M
-
Which has Higher Returns LIVN or NVCR?
NovoCure Ltd. has a net margin of 7.49% compared to LivaNova Plc's net margin of -22.29%. LivaNova Plc's return on equity of -18.29% beat NovoCure Ltd.'s return on equity of -50.08%.
Company Gross Margin Earnings Per Share Invested Capital LIVNLivaNova Plc68.44% $0.49 $1.6B NVCRNovoCure Ltd.73.25% -$0.33 $1.1B -
What do Analysts Say About LIVN or NVCR?
LivaNova Plc has a consensus price target of $72.82, signalling upside risk potential of 13.05%. On the other hand NovoCure Ltd. has an analysts' consensus of $24.79 which suggests that it could grow by 72.72%. Given that NovoCure Ltd. has higher upside potential than LivaNova Plc, analysts believe NovoCure Ltd. is more attractive than LivaNova Plc.
Company Buy Ratings Hold Ratings Sell Ratings LIVNLivaNova Plc6 2 0 NVCRNovoCure Ltd.4 2 0 -
Is LIVN or NVCR More Risky?
LivaNova Plc has a beta of 0.973, which suggesting that the stock is 2.741% less volatile than S&P 500. In comparison NovoCure Ltd. has a beta of 0.735, suggesting its less volatile than the S&P 500 by 26.501%.
-
Which is a Better Dividend Stock LIVN or NVCR?
LivaNova Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NovoCure Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LivaNova Plc pays -- of its earnings as a dividend. NovoCure Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LIVN or NVCR?
LivaNova Plc quarterly revenues are $357.8M, which are larger than NovoCure Ltd. quarterly revenues of $167.2M. LivaNova Plc's net income of $26.8M is higher than NovoCure Ltd.'s net income of -$37.3M. Notably, LivaNova Plc's price-to-earnings ratio is 38.16x while NovoCure Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LivaNova Plc is 2.61x versus 2.47x for NovoCure Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LIVNLivaNova Plc2.61x 38.16x $357.8M $26.8M NVCRNovoCure Ltd.2.47x -- $167.2M -$37.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Planet Labs Stock Rally So Much?
Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…
Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
71
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
Buy
54
LGIH alert for Jan 10
LGI Homes, Inc. [LGIH] is up 13.81% over the past day.
